| Entry |
|
|---|
| Name |
Compound oxycodone (JP18);
Pavinal (TN) |
|---|
| Component |
Oxycodone hydrochloride hydrate [DR: D05462], Hydrocotarnine hydrochloride [DR: D02031]
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (DG00813): | D05312<US> D00847<US> D05462<JP> |
|
|---|
| Efficacy |
Analgesic (narcotic), Antitussive, Opioid receptor agonist |
|---|
| Comment |
Opium alkaloid
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]; CYP2D6 [HSA: 1565]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02A OPIOIDS
N02AA Natural opium alkaloids
N02AA05 Oxycodone
D02175 Compound oxycodone (JP18)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG00813 Oxycodone
D02175 Compound oxycodone
Analgesic
DG01984 Opioid analgesics
DG00813 Oxycodone
D02175 Compound oxycodone
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00813 Oxycodone
D02175 Compound oxycodone
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00813 Oxycodone
D02175 Compound oxycodone
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D02175 Compound oxycodone injection
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02175
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG00813 Oxycodone
Analgesic
DG01984 Opioid analgesics
DG00813 Oxycodone
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00813 Oxycodone
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00813 Oxycodone
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
